Press Releases

Date Title and Summary Additional Formats
Toggle Summary Radius Health Provides Update on Appeal of CHMP Opinion for Abaloparatide-SC
WALTHAM, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in the areas of osteoporosis and oncology, today announced that
View HTML
Toggle Summary Radius Health to Announce Second Quarter 2018 Financial Results, Host Conference Call and Live Webcast on August 7, 2018
WALTHAM, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its second quarter financial results on Tuesday, August 7, 2018. The Company will host a conference call and live audio webcast at 8:00 a.m.
View HTML
Toggle Summary Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., July 16, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq:RDUS) today announced that the Compensation Committee of the Company's Board of Directors granted Chhaya Shah, in connection with her appointment as the Company's Senior Vice President,
View HTML
Toggle Summary Radius Health Strengthens Senior Management Team with Appointment of Chhaya Shah as Senior Vice President of Technical Operations
WALTHAM, Mass., July 16, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq:RDUS) today announced the appointment of Chhaya Shah as Senior Vice President of Technical Operations. "Ms. Shah will help strengthen and expand our technical operations infrastructure,
View HTML
Toggle Summary Radius Health to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
WALTHAM, Mass., June 07, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that Jesper Høiland, President and Chief Executive Officer and Pepe Carmona, Senior Vice President and Chief Financial Officer of the Company, will present a corporate update at the at the Goldman
View HTML
Toggle Summary Radius to Host Investor Day on June 8, 2018
Advancing Treatment Care for Osteoporosis
View HTML
Toggle Summary Radius Health to Present at the Bank of America Merrill Lynch 2018 Annual Healthcare Conference
WALTHAM, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that Jesper Høiland, President and Chief Executive officer and Pepe Carmona, Senior Vice President and Chief Financial Officer of the Company, will present a corporate update at the Bank of America
View HTML
Toggle Summary Radius Health Reports First Quarter 2018 Financial and Operating Results and Provides Business Update
First quarter 2018 TYMLOS® sales increase to $14.5 million, a 90% increase  over the fourth quarter of 2017 TYMLOS captured on average 13% of the U.S. anabolic osteoporosis market and 31% of new anabolic patient starts in the quarter Radius targets TYMLOS capturing on average 19-21% of the U.S.
View HTML
Toggle Summary Radius Health to Announce First Quarter 2018 Financial Results, Host Conference Call and Live Webcast on May 10, 2018
WALTHAM, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its first quarter financial results on Thursday, May 10, 2018. The Company will host a conference call and live audio webcast at 8:00 a.m.
View HTML
Toggle Summary Radius Health Initiates Phase 3 Clinical Trial of Abaloparatide Injection for the Treatment of Male Osteoporosis
Bridging study will evaluate change in spine bone mineral density (BMD) at 12 months compared with placebo
View HTML